It has been about a month since the last earnings report for Mirum Pharmaceuticals, Inc. (MIRM) . Shares have lost about 3.4% in that time frame, underperforming the S&P 500. Will the recent negative trend continue leading up to its next earnings release, or is Mirum Pharmaceuticals due for a breakout? Before we dive into how investors and analysts have reacted as of late, let's take a quick look at the most recent earnings report in order to get a better handle on the important drivers. Mirum's Q1 Earnings ...